SCHEMBL1689509

SCHEMBL1689509

CSc1snc2c1c(=O)n(C)c(=O)n2C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
ADORA2A P29274 3/20 0.37
PIK3CD O00329 1/20 0.35
POLB P06746 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
CNR1 P21554 1/20 0.35
ACHE P22303 1/20 0.35
ADORA2B P29275 1/20 0.35
ADORA1 P30542 1/20 0.35
NTSR1 P30989 1/20 0.35
MC3R P41968 1/20 0.35
NOTUM Q6P988 1/20 0.35
SIRT3 Q9NTG7 1/20 0.35
GDA Q9Y2T3 1/20 0.35
NR2E1 Q9Y466 1/20 0.35
ALDH1A1 P00352 3/20 0.35
ATAD2 Q6PL18 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
MAOA P21397 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9972908 0.72 KMT2A (0.44) KDM4EADORA2APIK3CDPOLBADORA3
SCHEMBL9972885 0.72 KDM4E (0.41) KDM4EADORA2AADORA2BALDH1A1KMT2A
SCHEMBL14972716 0.71 KDM4E (0.36) KDM4EADORA2APIK3CDPOLBADORA3
SCHEMBL1689535 0.68 ADORA2B (0.40) KDM4EADORA2AADORA2BALDH1A1KMT2A
SCHEMBL3716133 0.68 ADORA2B (0.38) KDM4EADORA2APIK3CDPOLBADORA3
SCHEMBL475287 0.67 ADORA2B (0.37) KDM4EPOLBADORA2BALDH1A1KMT2A
SCHEMBL13190508 0.67 ALOX15 (0.42) KDM4EADORA2BALDH1A1
SCHEMBL14981101 0.65 ALDH1A1 (0.36) KDM4EPOLBALDH1A1KMT2A
SCHEMBL3716134 0.63 ALDH1A1 (0.38) KDM4EADORA2AADORA2BALDH1A1MAPK1
SCHEMBL14981131 0.63 TNF (0.44) KDM4EPOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575178-B2 Isothiazolo-pyrimidinedione derivatives as TRPA1 modulators GLENMARK PHARMACEUTICALS S.A. (CH) 2013-11-05 US disclosed
EP-2411397-B1 ISOTHIAZOLO-PYRIMIDINEDIONE DERIVATIVES AS TRPA1 MODULATORS GLENMARK PHARMACEUTICALS SA (CH) 2013-05-29 EP disclosed
US-20120010223-A1 ISOTHIAZOLO-PYRIMIDINEDIONE DERIVATIVES AS TRPAI MODULATORS GLENMARK PHARMACEUTICALS, S.A. (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010223-A1 ISOTHIAZOLO-PYRIMIDINEDIONE DERIVATIVES AS TRPAI MODULATORS TRPA1, TRPV1, TRPC3 KDM4E 4779/4885ADORA2A 67/4885PIK3CD 1435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.